Thrombocytopenic Purpura
Trial data show Promacta lowers bleeding, raises platelet count in thrombocytopenic purpura
Published in Hematology Week, January 8th, 2007
Analysis of data from this study showed that Promacta at 50 mg or 75 mg resulted in a positive trend in decrease in bleeding incidence (all grades) in adult patients with chronic idiopathic thrombocytopenic purpura (ITP), an autoimmune condition which results in low blood platelet counts and bleeding from the small blood vessels. These data were presented at the 48th Annual American Society of Hematology (ASH) meeting in Orlando, Florida.
The primary efficacy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2007-01-08)
More Articles from Hematology Week
- Hematology
New Evoltra data show impressive response and survival rates - Leukemia
New options treat chronic myeloid leukemia, overcome imatinib resistance - Acute Promyelocytic Leukemia Therapy
New acute promyelocytic leukemia therapy research reported from University of Rome, Department of Internal Medicine - Hemophilia A Epidemiology
New hemophilia a epidemiology data have been reported by researchers at Emory University, Aflac Cancer Center and Blood Disorders Service - Neutropenia
Findings from University of Bonn in neutropenia in children reported - Neutropenia Therapy
Findings from Kyungpook National University, Department of Psychiatry advance knowledge in neutropenia therapy - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
